AOXING PHARMACEUTICAL CO INC (OTCMKTS:AOXG) Has Increase in Shorts

June 18, 2018 - By Marguerite Chambers

The stock of AOXING PHARMACEUTICAL CO INC (OTCMKTS:AOXG) registered an increase of 200% in short interest. AOXG’s total short interest was 900 shares in June as published by FINRA. Its up 200% from 300 shares, reported previously.

It closed at $0.045 lastly. It is down 0.00% since June 18, 2017 and is . It has underperformed by 12.57% the S&P500.

Aoxing Pharmaceutical Company, Inc. a specialty pharmaceutical company, engages in research and development, manufacture, and distribution of narcotic, pain-management, and addiction treatment pharmaceutical products primarily in the People's Republic of China. The company has market cap of $3.43 million. The company's principal products include Zhongtong'an, a capsule of herbal extraction for the indication of oral and dental pain; and Yiqi Qiangshen Granule, an OTC herbal extraction for tonifying qi and empowering body, and promoting blood circulation to remove meridian obstruction, as well as Tilidine hydrochloride, an orally-absorbed synthetic narcotic analgesic tablet used in 50mg or 100mg dosage for relief of acute, moderate to severe pain, and chronic cancer-related pain. It currently has negative earnings. The Company’s products under development comprise Oxycodone and Acetaminophen tablets and capsules, which has completed clinical trials for the treatment of acute and chronic pain; Buprenorphine/Naloxone, a sublingual combo tablet that has completed Phase II clinical trials for the treatment of opioid dependence; and Tilidine/Naloxone, a compound capsule which is in Phase II clinical trial to treat acute and chronic pain.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: